(Q47373020)

15 January 2018

title

c-erbB-2 oncoprotein expression related to chemoradioresistance in esophageal squamous cell carcinoma (English)

1 reference

15 January 2018

esophageal squamous cell carcinoma

main subject

1 reference

Masayuki Akamatsu

1

1 reference

15 January 2018

Toshiharu Matsumoto

2

1 reference

15 January 2018

Kuniyuki Oka

3

1 reference

15 January 2018

Shigetaka Yamasaki

4

1 reference

15 January 2018

Hiroshi Sonoue

5

1 reference

15 January 2018

Yoshiaki Kajiyama

6

1 reference

15 January 2018

Masahiko Tsurumaru

7

1 reference

15 January 2018

Keisuke Sasai

8

1 reference

15 January 2018

language of work or name

English

0 references

publication date

1 December 2003

1 reference

15 January 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

15 January 2018

volume

57

1 reference

15 January 2018

issue

5

1 reference

15 January 2018

page(s)

1323-1327

1 reference

15 January 2018

p53CM1 expression is not associated with prognosis in uterine cervical carcinoma

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900782-X

7 January 2021

c-erbB-2 Oncoprotein expression is associated with poor prognosis in squamous cell carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900782-X

7 January 2021

Relationship between p21/WAF-1/CIP-1 and apoptosis in cervical cancer during radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900782-X

7 January 2021

Prognostic value of p53 mutations in patients with locally advanced esophageal carcinoma treated with definitive chemoradiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900782-X

7 January 2021

Histopathologic effects of neoadjuvant therapies for advanced squamous cell carcinoma of the esophagus: multivariate analysis of predictive factors and p53 overexpression

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900782-X

7 January 2021

Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900782-X

7 January 2021

Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900782-X

7 January 2021

The EGF receptor family as targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900782-X

7 January 2021

Prognostic significance of c -erb B-2 protein expression in carcinoma of the cervix treated with radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900782-X

7 January 2021

Anti-HER2-antibody enhances irradiation-induced growth inhibition in head and neck carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900782-X

7 January 2021

Tumour-proliferative fraction and growth factor expression as markers of tumour response to radiotherapy in cancer of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900782-X

7 January 2021

The lack of correlation between proliferation (Ki-67, PCNA, LI, Tpot), p53 expression and radiosensitivity for head and neck cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900782-X

7 January 2021

10.1016/S0360-3016(03)00782-X

Identifiers

DOI

1 reference

15 January 2018

1 reference

15 January 2018